e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Cough, airway hyperresponsiveness and asthma control
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The assessment of exhaled nitric oxide fraction in monitoring asthma control: How to raise the clinical relevance?
V. Tudorache, O. Fira-Mladinescu, C. Babiciu, M. Marc (Timisoara, Romania)
Source:
Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control
Session:
Cough, airway hyperresponsiveness and asthma control
Session type:
E-Communication Session
Number:
248
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Tudorache, O. Fira-Mladinescu, C. Babiciu, M. Marc (Timisoara, Romania). The assessment of exhaled nitric oxide fraction in monitoring asthma control: How to raise the clinical relevance?. Eur Respir J 2010; 36: Suppl. 54, 248
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Does the measurement of exhaled nitric oxide before and after specific inhalation challenges improve the diagnosis of occupational asthma?
Source: International Congress 2019 – Occupational lung diseases: from diagnostic techniques to classical and novel causes
Year: 2019
Clinical usefulness of fractional exhaled nitric oxide (FeNO) as a marker of long-term asthma control
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009
Is exhaled nitric oxide measurement useful in clinical practice?
Source: ISSN=ISSN 1810-6838, ISBN=, page=185
Year: 2006
An eye to the future: exhaled nitric oxide as a predictor of clinical outcomes in asthma
Source: Eur Respir J 2010; 35: 1200-1202
Year: 2010
Does treatment guided by exhaled nitric oxide fraction improve outcomes in subgroups of children with asthma?
Source: Eur Respir J, 55 (5) 1901879; 10.1183/13993003.01879-2019
Year: 2020
Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD
Source: Breathe, 15 (4) 306; 10.1183/20734735.0268-2019
Year: 2019
Assessing asthma control: questionnaires and exhaled nitric oxide provide complementary information
Source: Eur Respir J 2008; 32: 1419-1420
Year: 2008
Accuracy of exhaled nitric oxide to predict a loss of asthma control in well-controlled patients
Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Year: 2010
Improvement of asthma control assessed by exhaled nitric oxide: a real-life longitudinal study
Source: Eur Respir J 2005; 26: Suppl. 49, 276s
Year: 2005
By how much can exhaled nitric oxide vary without a change in clinical status?
Source: International Congress 2017 – Diagnostic tools and comorbidities in paediatric asthma
Year: 2017
Clinical utility of fractional exhaled nitric oxide in severe asthma management
Source: Eur Respir J, 55 (3) 1901633; 10.1183/13993003.01633-2019
Year: 2020
Comparison of asthma control test and exhaled nitric oxide to predict asthma control
Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control
Year: 2010
Is exhaled nitric oxide (eNO) an indipendent outcome measure in chronic stable asthma?
Source: Eur Respir J 2002; 20: Suppl. 38, 196s
Year: 2002
Clinical utility of nitric oxide metabolite level assessment in blood of patients with bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 424s
Year: 2002
Predictive value of exhaled nitric oxide in the management of asthma: a systematic review
Source: Eur Respir J 2016; 48: 706-714
Year: 2016
The impact of fractional exhaled nitric oxide (FeNO) measurement on treatment decision making in the specialist care of established asthma
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Exhaled nitric oxide in specific challenge tests to assess occupational asthma
Source: Eur Respir J 2002; 20: 1532-1537
Year: 2002
Usefulness of fraction of exhaled nitric oxide and asthma management questionnaires in predicting a future risk of asthma exacerbation
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019
Self-reported asthma control correlates with fraction of exhaled nitric oxide and lung function
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept